Observational Study of iv Ibandronate in Women With Postmenopausal Osteoporosis
NCT02271204
·
clinicaltrials.gov ↗
COMPLETED
Status
700
Enrollment
OTHER
Sponsor class
Conditions
Osteoporosis
Interventions
DRUG:
Ibandronic acid
Sponsor
Clinic of Endocrinology and Metabolic Disorders, Macedonia
Collaborators
[object Object]
[object Object]
[object Object]
[object Object]